NIH Information Quality
Expert Panel Report on the Management of Sickle Cell Disease
| Document, Report, or Other Product Information | |
|---|---|
| Title: | Expert Panel Report on the Management of Sickle Cell Disease |
| Subject: | Clinical management of sickle cell disease and its complications across the lifespan |
| Purpose (e.g., abstract): | To enable research findings to inform clinical practice, the NHLBI appointed an Expert Panel to develop clinical practice guidelines that can enhance the ability of people with SCD to receive appropriate care, support primary care and specialty physicians |
| Information Product Contact | |
| ISI or HISA: | ISI |
| Link to Information Product: | |
| IC: | NHLBI |
| IC Division, Office, or Program: | OST/NHLBI |
| NIH Contact: | Carl
Roth 301-496-1051 [email protected] |
| Reviewer Names and Expertise: | |
| Review Description: | |
| Date of Review: | |
| Number of Reviewers: | 12 |
| Reviewer Nominations Requested? | |
| Upcoming Panels, Events: | View Upcoming Panels, Events, Notices, Meeting Updates |
| Technical/Draft Reports, Public Comments and Presentations: | http://www.nhlbi.nih.gov/guidelines/scd/overview.htm |
| Past Roster, Notices, Meeting Updates: | View Past Roster, Notices, Meeting Updates |
| Reviewer Expertise: | Scientists with relevant expertise including, but not limited to Hematology, Oncology, medicine, Sickle Cell treatment, Obstetrics & Gynecology, and Healthcare Systems. |
| How Selected: | |
| Opportunity for Public Comment? | |
| Did any reviewers require any exception to the applicable independence or COI standards of the Bulletin, including determination by the Sec./Dep. Sec. pursuant to Section (3)(c)? | |
| Were any waivers, deferrals, exemptions, or alterative peer review processes used? | |
| Any Public Meetings? | |
| Number of Public Comments Received | |
This page last reviewed on